Ignite Creation Date:
2024-05-05 @ 4:38 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00287885
Status:
COMPLETED
Last Update Posted:
2017-11-29
First Post:
2006-02-06
Brief Title:
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer
Sponsor:
Masonic Cancer Center University of Minnesota
Organization:
Masonic Cancer Center University of Minnesota
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Vulvar Cancer |
| Cervical Cancer |
| Endometrial Cancer |
| Fallopian Tube Cancer |
| Ovarian Cancer |
| Peritoneal Cavity Cancer |
| Sarcoma |
| Vaginal Cancer |
Keywords:
| Name | View |
|---|---|
| peritoneal cavity cancer | View |
| recurrent cervical cancer | View |
| stage III cervical cancer | View |
| stage IVA cervical cancer | View |
| stage IVB cervical cancer | View |
| stage III endometrial carcinoma | View |
| recurrent endometrial carcinoma | View |
| stage IV endometrial carcinoma | View |
| fallopian tube cancer | View |
| stage III ovarian epithelial cancer | View |
| stage IV ovarian epithelial cancer | View |
| stage III ovarian germ cell tumor | View |
| recurrent ovarian germ cell tumor | View |
| stage IV ovarian germ cell tumor | View |
| recurrent ovarian epithelial cancer | View |
| recurrent uterine sarcoma | View |
| stage III uterine sarcoma | View |
| stage IV uterine sarcoma | View |
| stage III vaginal cancer | View |
| recurrent vaginal cancer | View |
| stage IVA vaginal cancer | View |
| stage IVB vaginal cancer | View |
| stage III vulvar cancer | View |
| recurrent vulvar cancer | View |
| stage IV vulvar cancer | View |
| ovarian sarcoma | View |
| ovarian stromal cancer | View |